tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

SAGE Stock Latest News

Sage Therapeutics price target raised to $63 from $60 at RBC Capital
The FlySage Therapeutics price target raised to $63 from $60 at RBC Capital
1M ago
SAGE
Is SAGE a Buy, Before Earnings?
Pre-EarningsIs SAGE a Buy, Before Earnings?
1M ago
SAGE
Sage Therapeutics participates in a conference call hosted by Piper Sandler
The FlySage Therapeutics participates in a conference call hosted by Piper Sandler
3M ago
SAGE
Sage Therapeutics participates in a conference call hosted by Piper Sandler
The FlySage Therapeutics participates in a conference call hosted by Piper Sandler
3M ago
SAGE
RBC upgrades Sage Therapeutics on doctor survey, share selloff
The FlyRBC upgrades Sage Therapeutics on doctor survey, share selloff
3M ago
SAGE
SIVB
Sage Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
The FlySage Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
3M ago
SAGE
No ad com suggests positive potential outcome for Sage’s zura, says BofA
The FlyNo ad com suggests positive potential outcome for Sage’s zura, says BofA
3M ago
BIIB
SAGE
Biogen, Sage Therapeutics: FDA has no plans to discuss NDA for zuranolone
The FlyBiogen, Sage Therapeutics: FDA has no plans to discuss NDA for zuranolone
3M ago
BIIB
SAGE
Sage Therapeutics: EMA grants Orphan Drug Designation to SAGE-718
The FlySage Therapeutics: EMA grants Orphan Drug Designation to SAGE-718
3M ago
SAGE
Sage Therapeutics price target raised to $45 from $37 at Mizuho
The FlySage Therapeutics price target raised to $45 from $37 at Mizuho
4M ago
SAGE
Sage Therapeutics reports Q4 EPS ($2.47) , consensus ($2.39)
The FlySage Therapeutics reports Q4 EPS ($2.47) , consensus ($2.39)
4M ago
SAGE
Biogen, Sage Therapeutics: FDA accepts NDA for zuranolone
The FlyBiogen, Sage Therapeutics: FDA accepts NDA for zuranolone
4M ago
BIIB
SAGE
Sage Therapeutics downgraded to Neutral from Buy at Guggenheim
The FlySage Therapeutics downgraded to Neutral from Buy at Guggenheim
5M ago
SAGE
Sage Therapeutics management to meet with Piper Sandler
The FlySage Therapeutics management to meet with Piper Sandler
6M ago
SAGE
Sage Therapeutics management to meet with Piper Sandler
The FlySage Therapeutics management to meet with Piper Sandler
6M ago
SAGE
Biogen and Sage Therapeutics to hold a joint investor webcast
The FlyBiogen and Sage Therapeutics to hold a joint investor webcast
6M ago
BIIB
SAGE
Sage Therapeutics, Biogen complete NDA to FDA for zuranolone
The FlySage Therapeutics, Biogen complete NDA to FDA for zuranolone
6M ago
BIIB
SAGE
Biogen and Sage Therapeutics to hold a joint investor webcast
The FlyBiogen and Sage Therapeutics to hold a joint investor webcast
6M ago
BIIB
SAGE
Biogen and Sage Therapeutics to hold a joint investor webcast
The FlyBiogen and Sage Therapeutics to hold a joint investor webcast
6M ago
BIIB
SAGE
Sage Therapeutics (NASDAQ:SAGE) Rises as CEO Loads Up On Stock
Market NewsSage Therapeutics (NASDAQ:SAGE) Rises as CEO Loads Up On Stock
7M ago
SAGE
Sage Therapeutics price target lowered to $50 from $55 at H.C. Wainwright
The FlySage Therapeutics price target lowered to $50 from $55 at H.C. Wainwright
7M ago
SAGE
Sage Jumps on Positive Data from SAGE-718 Trial
Market NewsSage Jumps on Positive Data from SAGE-718 Trial
1y ago
SAGE